CASI Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Cash & Equivalents	17.08	47.11	38.7	57.06	53.62	84.21	43.49	27.09	5.13	10.67	Upgrade
Short-Term Investments	13.69	4.23	9.87	9.31	0.63	0.91	0	0	0	0	Upgrade
Cash & Cash Equivalents	30.77	51.34	48.57	66.37	54.25	85.12	43.49	27.09	5.13	10.67	Upgrade
Cash Growth	-40.06%	5.69%	-26.82%	22.36%	-36.27%	95.72%	60.52%	428.01%	-51.91%	-29.49%	Upgrade
Receivables	10.14	12.97	9.8	4.65	1.29	0	0	0	0	0.02	Upgrade
Inventory	15.88	6.14	1.91	1.36	4.54	0.28	0	0	0	0	Upgrade
Other Current Assets	2.56	2.98	1.69	1.65	4.64	7.17	0.32	0.36	0.44	0.33	Upgrade
Total Current Assets	59.34	73.42	61.97	74.03	64.72	92.57	43.81	27.45	5.57	11.02	Upgrade
Property, Plant & Equipment	11.63	13.23	21.82	10.76	9.69	1.75	1.05	0.23	0.22	0.26	Upgrade
Long-Term Investments	1.69	7.46	40.13	29.44	14.04	0	0	0	0	0	Upgrade
Goodwill and Intangibles	1.84	1.06	12.2	13.21	13.67	18.79	0	0	0	0	Upgrade
Other Long-Term Assets	0.77	1.06	2.18	0.3	0.5	0.31	0.24	0.03	0.04	0.03	Upgrade
Total Long-Term Assets	15.92	22.81	76.33	53.71	37.91	20.85	1.29	0.26	0.26	0.29	Upgrade
Total Assets	75.27	96.23	138.3	127.73	102.63	113.41	45.1	27.71	5.83	11.31	Upgrade
Accounts Payable	4.44	3.29	2.22	3.26	5.11	0.97	4.32	1.06	0.88	0.75	Upgrade
Deferred Revenue	0	0	2.83	2.35	0	0	0	0	0	0	Upgrade
Current Debt	0	0	0	1.29	0	1.5	0	0	0	0	Upgrade
Other Current Liabilities	12.29	13.72	8.14	1.07	2.83	1.41	0.75	0.25	0.17	0.16	Upgrade
Total Current Liabilities	16.73	17.01	13.19	7.98	7.95	3.87	5.06	1.32	1.05	0.92	Upgrade
Long-Term Debt	18.9	0	0	0	0	0	1.5	1.49	1.46	1.39	Upgrade
Other Long-Term Liabilities	15.48	12.3	17.15	16.19	1.02	0.07	0	4.12	9.4	9.42	Upgrade
Total Long-Term Liabilities	34.38	12.3	17.15	16.19	1.02	0.07	1.5	5.61	10.86	10.81	Upgrade
Total Liabilities	51.1	29.3	30.34	24.16	8.97	3.95	6.56	6.93	11.91	11.73	Upgrade
Total Debt	18.9	0	0	1.29	0	1.5	1.5	1.49	1.46	1.39	Upgrade
Debt Growth	-	-	-	-	-	0.02%	0.50%	1.80%	5.39%	-	Upgrade
Retained Earnings	-660.82	-637.16	-605.64	-570.5	-523.91	-478.94	-452.7	-441.93	-432.48	-425.27	Upgrade
Comprehensive Income	-1.2	-0.7	1.95	0.59	-2.73	-1.23	0	0	0	0	Upgrade
Shareholders' Equity	24.17	44.57	84.5	81.54	73	109.46	38.54	20.78	-6.09	-0.42	Upgrade
Net Cash / Debt	11.87	51.34	48.57	65.08	54.25	83.62	41.99	25.6	3.67	9.28	Upgrade
Net Cash / Debt Growth	-76.87%	5.69%	-25.37%	19.97%	-35.13%	99.13%	64.02%	598.33%	-60.49%	-38.67%	Upgrade
Net Cash Per Share	0.89	3.76	3.57	5.89	5.65	9.87	6.83	4.58	1.13	3.25	Upgrade
Working Capital	42.62	56.42	48.78	66.05	56.78	88.69	38.75	26.13	4.52	10.1	Upgrade
Book Value Per Share	1.81	3.27	6.21	7.38	7.61	12.92	6.26	3.72	-1.88	-0.15	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).